Literature DB >> 31712711

Correlation between blood pressure variability and subclinical target organ damage in patients with essential hypertension.

Mostafa El Mokadem1, Hesham Boshra2, Yasser Abd El Hady2, Amany Kasla3, Ahmed Gouda4.   

Abstract

High blood pressure (BP) variability is associated with the increased risk of cardiovascular and renal damage together with increased cardiovascular mortality. The aim of our study was to investigate the relationship between BP variability and subclinical target organ damage (TOD) in patients with controlled essential hypertension. One hundred patients with controlled essential hypertension were randomly selected from outpatient clinic of Beni-Suef University hospital. All patients were subjected to full history taking, physical examination, three separate office BP measurements for assessment of long-term BP variability, ambulatory BP monitoring for short-term variability, and finally different investigations for subclinical TOD. We had 73 patients with subclinical TOD. Long-term visit-to-visit variability was evaluated by measuring SD (standard deviation) and CV (coefficient of variance) of systolic and diastolic BP. None of the parameters of long-term BP variability were significantly higher among patients with TOD compared with those without TOD. For short-term variability evaluated by ambulatory BP monitoring, average real variability (ARV) was the only parameter that had a significant consistent association with TOD in contrast to SD and CV. Finally, Daytime systolic ARV, nighttime diastolic ARV, and age were independent predictors of TOD (P values = 0.014, 0.018, 0.047, and 0.02, respectively). We concluded that ARV could be an appropriate index of BP variability and a more useful predictor of TOD in contrast to other parameters of BP variability.

Entities:  

Mesh:

Year:  2019        PMID: 31712711     DOI: 10.1038/s41371-019-0286-8

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  11 in total

1.  Prognostic significance of blood pressure variability in essential hypertension.

Authors: 
Journal:  Blood Press Monit       Date:  1996-02       Impact factor: 1.444

Review 2.  Blood Pressure Variability: Assessment, Prognostic Significance and Management.

Authors:  M Chenniappan
Journal:  J Assoc Physicians India       Date:  2015-05

3.  Impact of ambulatory blood pressure variability on cerebral small vessel disease progression and cognitive decline in community-based elderly Japanese.

Authors:  Yoshitaka Yamaguchi; Manabu Wada; Hidenori Sato; Hikaru Nagasawa; Shingo Koyama; Yoshimi Takahashi; Toru Kawanami; Takeo Kato
Journal:  Am J Hypertens       Date:  2014-03-20       Impact factor: 2.689

4.  Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study.

Authors:  Eamon Dolan; Alice Stanton; Lut Thijs; Kareem Hinedi; Neil Atkins; Sean McClory; Elly Den Hond; Patricia McCormack; Jan A Staessen; Eoin O'Brien
Journal:  Hypertension       Date:  2005-06-06       Impact factor: 10.190

5.  Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations.

Authors:  Tine W Hansen; Lutgarde Thijs; Yan Li; José Boggia; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2010-03-08       Impact factor: 10.190

6.  Short-Term Blood Pressure Variability Relates to the Presence of Subclinical Brain Small Vessel Disease in Primary Hypertension.

Authors:  Josefina Filomena; Iolanda Riba-Llena; Ernest Vinyoles; José L Tovar; Xavier Mundet; Xavier Castañé; Andrea Vilar; Antonio López-Rueda; Joan Jiménez-Baladó; Anna Cartanyà; Joan Montaner; Pilar Delgado
Journal:  Hypertension       Date:  2015-06-22       Impact factor: 10.190

Review 7.  Hypertensive retinopathy: a review of existing classification systems and a suggestion for a simplified grading system.

Authors:  P M Dodson; G Y Lip; S M Eames; J M Gibson; D G Beevers
Journal:  J Hum Hypertens       Date:  1996-02       Impact factor: 3.012

8.  Blood pressure variability and prognosis in uncomplicated mild hypertension.

Authors:  Sante D Pierdomenico; Domenico Lapenna; Anna Bucci; Bianca M Manente; Mariantonietta Mancini; Franco Cuccurullo; Andrea Mezzetti
Journal:  Am Heart J       Date:  2005-05       Impact factor: 4.749

9.  Factors affecting ambulatory blood pressure reproducibility. Results of the HARVEST Trial. Hypertension and Ambulatory Recording Venetia Study.

Authors:  P Palatini; P Mormino; C Canali; M Santonastaso; G De Venuto; G Zanata; A C Pessina
Journal:  Hypertension       Date:  1994-02       Impact factor: 10.190

10.  Blood Pressure Variability and Left Ventricular Mass in Hypertensive Patients.

Authors:  E R Mustafa; O Istrătoaie; R Mușetescu
Journal:  Curr Health Sci J       Date:  2016-03-29
View more
  3 in total

1.  Correlation between serum miR-122 and myocardial damage and ventricular function in patients with essential hypertension.

Authors:  Liangguo Wang; Huabing Chen
Journal:  J Thorac Dis       Date:  2021-08       Impact factor: 3.005

2.  Association between ambulatory blood pressure variability and frailty among older hypertensive patients.

Authors:  Yingqian Zhu; Xin Chen; ShaSha Geng; QingQing Li; Huixiao Yuan; Xi Zhou; Huan Li; Jinglan Li; Hua Jiang
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-28       Impact factor: 3.738

3.  Correlation among high salt intake, blood pressure variability, and target organ damage in patients with essential hypertension: Study protocol clinical trial (SPIRIT compliant).

Authors:  Wei Cai; MingJian Lang; XiaoBo Jiang; Qian Yu; Congliang Zhou; Wenshu Zou; Xiaohua Zhang; JianGuo Lei
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.